Work

Will CAR T cell therapy have a role in AML? Promises and pitfalls

Year: 2018

Type: review

Source: Seminars in Hematology

DOI: 10.1053/j.seminhematol.2018.08.008

Authors: Katherine D. Cummins, Saar Gill

Institution: University of Pennsylvania

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Novartis Pharmaceuticals Corporation, National Cancer Institute

Award: Chimeric Antigen Receptor T cell Therapy for Acute Myeloid Leukemia (AML)

OpenAlex ID: W2889359744

FWCI: 0.66

Cites: 67

Cited by: 65

Related to: 10